Posted 5:00 PM 2/12/2013 by Robert Preidt
TUESDAY, Feb. 12 (HealthDay News) -- Sometimes, simply watching and waiting is a safe alternative to surgery for older patients with small kidney tumors, a new study suggests.
"Physicians can comfortably tell an elderly patient, especially a patient that is not healthy enough to tolerate (More)
Posted 10:00 AM 2/11/2013 by By Randy Dotinga
MONDAY, Feb. 11 (HealthDay News) -- Preliminary research produced promising results for a cancer-fighting drug that piggybacks on a virus similar to the one used in the smallpox vaccine.
Patients with advanced liver cancer who were given higher doses of the drug lived months longer than (More)
Posted 2:36 PM 2/8/2013 by Scott Roberts
FRIDAY, Feb. 8 (HealthDay News) -- Pomalyst (pomalidomide) has been approved by the U.S. Food and Drug Administration to treat cases of multiple myeloma that have not responded to other therapies.
The disease, a form of blood cancer, affects some 21,700 Americans annually and nearly 10,700 (More)
Posted 5:00 PM 2/7/2013 by By Steven Reinberg
THURSDAY, Feb. 7 (HealthDay News) -- The hassles and deadlines at work may leave you frazzled, but they won't raise your risk for cancer, new research suggests.
Despite earlier studies suggesting an association between work stress and cancer, an international team of researchers found that (More)
Posted 12:00 PM 2/6/2013 by Robert Preidt
WEDNESDAY, Feb. 6 (HealthDay News) -- Doctors need to be on the lookout for another counterfeit version of the injectable cancer drug Avastin (bevacizumab), the U.S. Food and Drug Administration warned on Wednesday.
Lab tests revealed that at least one batch of the counterfeit medicine -- (More)
Posted 10:00 AM 2/5/2013 by By Kathleen Doheny
TUESDAY, Feb. 5 (HealthDay News) -- For older women ages 66 to 74, getting a mammogram every two years appears as good as getting one every year, according to a new study.
"Your risk of having breast cancer detected at a later stage is no greater if you screen every two years compared to (More)
Posted 2:00 PM 2/4/2013 by Scott Roberts
MONDAY, Feb. 4 (HealthDay News) -- The first generic version of the cancer drug Doxil (doxorubicin hydrochloride liposome injection) has been approved by the U.S. Food and Drug Administration, which says the action should help relieve shortages of the brand-name medication.
Doxil is on the (More)